PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
1.89M / 3.59M (Avg.)
-1.60 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2454289.24%
10Y revenue/share CAGR under 50% of SMR.AX's 20320023.59%. Michael Burry would suspect a lasting competitive disadvantage.
3243.04%
5Y CAGR of 3243.04% while SMR.AX is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
66.54%
3Y revenue/share CAGR at 75-90% of SMR.AX's 87.29%. Bill Ackman would expect new product strategies to close the gap.
160.42%
OCF/share CAGR of 160.42% while SMR.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
184.59%
OCF/share CAGR of 184.59% while SMR.AX is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
-41.57%
Negative 3Y OCF/share CAGR while SMR.AX stands at 332.82%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
74.81%
Below 50% of SMR.AX's 3175.60%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-130.87%
Negative 5Y net income/share CAGR while SMR.AX is 0.00%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-165.21%
Negative 3Y CAGR while SMR.AX is 16.74%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-103.80%
Negative equity/share CAGR over 10 years while SMR.AX stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-6.15%
Negative 5Y equity/share growth while SMR.AX is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-258.04%
Negative 3Y equity/share growth while SMR.AX is at 25.08%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.